PATENT CLAIM ANALYSIS

Application Number: 16081550
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "007200"]

Abstract:
The present invention relates to the GLP-1 receptor agonist liraglutide for use in medicine.

Claim (Index 21):
The method according to  claim 20 , wherein the liraglutide is administered at 0.6 mg per day.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 96.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15401651', '15616974', '15354053', '14918713', '13295174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7013928575295911
- 35 USC 102 Novelty (BERT): 0.5016950116984752
- Combined Prediction Score: 0.6814230729464795
- Mean Citation Score: 181.929686
- Max Citation Score: 257.79913
- Similarity Product: 197.33166815006007

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test